Feasibility and usability of a regional hub model for colorectal cancer services during the COVID-19 pandemic - Scorecard - MDSpire

Feasibility and usability of a regional hub model for colorectal cancer services during the COVID-19 pandemic

  • By

  • Filipe Carvalho

  • Ailín C. Rogers

  • Tou-Pin Chang

  • Yinshan Chee

  • Dhivya Subramaniam

  • Gianluca Pellino

  • Katy Hardy

  • Christos Kontovounisios

  • Paris Tekkis

  • Shahnawaz Rasheed

  • March 3, 2022

  • 0 min

Share

Clinical Scorecard: Assessment of the Regional Hub Model for Colorectal Cancer Services During the COVID-19 Crisis

At a Glance

CategoryDetail
ConditionColorectal and anal cancer requiring elective surgery
Key MechanismsCentralised regional hub model to provide COVID-19 free surgical pathways and prioritise cancer surgery during pandemic resource constraints
Target PopulationPatients with colorectal or anal cancer in the London region requiring time-critical surgery
Care SettingDesignated COVID-19 free surgical sites within NHS trusts and private hospitals in London

Key Highlights

  • The RM Partners Cancer Hub centralized colorectal cancer surgery across London during the COVID-19 pandemic to maintain elective cancer care.
  • Patients were prioritized based on NHS England guidelines into urgent surgical categories to mitigate delays and complications.
  • Two COVID-19 free sites (Royal Marsden Hospital and BUPA Cromwell Hospital) were designated to safely deliver elective cancer surgery.

Guideline-Based Recommendations

Diagnosis

  • Patients underwent diagnostics and multidisciplinary team (MDT) discussion at their local NHS Trust prior to referral.
  • Referral to the Cancer Hub required exclusion of active COVID-19 infection and completion of standardised online referral forms.

Management

  • Surgical treatment was centralized at COVID-19 free sites to minimize infection risk and resource conflicts.
  • Patients and their households were advised to self-isolate prior to surgery to reduce peri-operative COVID-19 exposure.
  • Clinical prioritisation followed NHS England guidelines categorizing patients by urgency (Priority 1a/1b and Priority 2).

Monitoring & Follow-up

  • Weekly multidisciplinary prioritisation meetings (Clinical Prioritisation Group) reviewed and scheduled cases within seven days of referral.

Risks

  • Peri-operative COVID-19 infection is associated with poor post-operative outcomes.
  • Delays in cancer surgery due to pandemic resource constraints risk disease progression and complications.

Patient & Prescribing Data

Patients with colorectal or anal cancer requiring elective surgery during the COVID-19 pandemic in London

Centralized surgical pathways at COVID-19 free sites allowed continuation of elective cancer surgery despite pandemic pressures, with prioritization to mitigate risks from delays and infection.

Clinical Best Practices

  • Establish regional collaborative networks to centralize cancer surgery during healthcare crises.
  • Designate COVID-19 free surgical sites with pre-admission screening and patient self-isolation protocols.
  • Implement standardized referral and prioritization processes with multidisciplinary oversight.
  • Maintain clear communication with patients regarding risks and infection control measures.

References

Original Source(s)

Related Content